СЕРОТОНИН: ОТ НЕЙРОМЕДИАТОРА ДО ЛЕКАРСТВЕННОГО СРЕДСТВА

Зайченко А. В., Горчакова Н. А.

ОБЗОРЫ ЛИТЕРАТУРЫ

Научная статья.

В обзорной статье приведены данные относительно истории открытия серотонина, его метаболизма, физиологических, биохимических фармакологических свойств, влияния на разные органы и системы. Обозначены виды серотонинэргических рецепторов и эффекты, которые возникают при их возбуждении и угнетении. Приведены данные относительно фармакологических свойств интермедианта серотонина-5-гидрокситриптофана и аспекты его применения в клинической практике в моно- и комплексной фармакотерапии.

серотонин, серотонинэргические рецепторы, физиологическое, фармакологическое действие, 5-гидрокситриптофан

1. Barinov E.F Rol serotonina v fiziologii i patologii zheludochno-kishechnogo trakta / E.F Barinov, O.N. Sulaeva // Ros. zhurnal gastroenterologii, gepatologii, kolopraktologii. - 2012. - T 21, № 2. - S. 4-13.
2. Gorelyishev A.S. Menstrualnyiy tsikl i energeticheskaya «politika» gipotalamusa / A.S. Gorelyishev, I.V. Kuznetsova // Effektivnaya farmakoterapiya. - 2015. - № 5. - S. 4-12.
3. Davyidova I.V. Serdechno-sosudistyie zabolevaniya u zhenschin v zavsimosti ot gormonalnogo kontinuuma: profilaktika i strategiya lecheniya / I.V. Davyidova, S.N. Mamyirenko, N.P Perepelchenko, L.I. Konoplyanik // Zdorove zhenschinyi. - 2016. - № 4. - S. 43-47.
4. Ivanets N.N. Svyaz polimorfizma 5NTTLPR gena serotoninovogo transportera s effektivnostyu i perenosimostyu selektivnyih ingibitorov obratnogo zahvata serotonina / N.N. Ivanets, M.A. Kankulkina, Yu.G. Tihonova [i dr.] // Zhurnal nevrologii i psihiatrii. - 2016. - № 2. - S. 46-51.
5. Kutko 1.1. Otsenka effektivnosti kombinirovannogo sredstva na osnove L-5-gidroksitriptofana (5-NTR) i melatonina v terapii insomnii / I.I. Kutko, I.F Tereshina, O.V. Kruglova // VIsnik problem bIologIYi I meditsini. - 2016. - Vip. 4, T 2. - S. 79-84.
6. Lyichkova A.E. Vliyanie serotonina na strukturno-funktsionalnoe sostoyanie pochek / V.E. Lyichkova, Yu.A. Hoschenko, PG. Osipov [i dr.] // Nauchnyie vedomosti. Seriya Meditsina. Farmatsiya. - 2016. - № 12, vyip. 34. - S. 22-26.
7. Naletov S.V. Klinicheskaya farmakologiya preparatov valerianyi i evropeyskie traditsii ih prieneniya: krushenie postsovetstkih stereotipov / S.V. Naletov // Ukr. med. chasopis. - 2009. - № 3. - S. 41-47.
8. Ochanov R.G. Depressii i rasstroystva depressivnogo spektra v obschemeditsinskoy praktike. Predvaritelnyie rezultatyi programmyi Kompas / R.G. Ochanov, L.I. Albinskaya, A.B. Smulevich [i dr.] // Kardiologiya. - 2004. - T 54, № 1. - S. 48-55.
9. Plotnikova E.Yu. Rol serotoninovyih retseptorov v dvigatelnoy aktivnosti pischevaritelnogo kanala / E.Yu. Plotnikova, O.A. Krasnov // Lechaschiy vrach. - 2014. - № 8. - S. 14-22.
10. Sadyikova TM. Rol serotoninergicheskoy sistemyi v razvitii zabolevaniy serdtsa i sosudov u detey / D.N. Sadyikova, R.R. Nimmatullina, G.N. Aflyaumova // Kazanskiy med. zhurnal. - 2015. - T 96, № 4. - S. 35-36.
11. Sveshnikov D.S. Serotoninergicheskie mehanizmyi regulyatsii prosveta sosudov bolshogo kruga krovoobrascheniya / D.S. Sveshnikov, A.V. Kuchuk, V.S. Smirnov, G.V. Cherepanova // Kazan. med. zhurnal. - 2016. - T 97, № 1. - S. 89-96.
12. Sviridova N.K. OsoblivostI lIkuvannya asteno-nevrotichnogo sindromu ta rozladIv snu u hvorih z hronIchnim porushennyam mozkovogo krovoobIgu / N.K. Sviridova, TP. Parikoza, V.G. Sereda // ShIdno-Evropeyskiy nevrologIchniy zhurnal. - 2016. - № 2. - S. 52-58.
13. Spasov A.A. 5-NT3-retseptoryi - mishen dlya vozdeystviya biologicheski aktivnyih soedineniy / A.A. Spasov, D.S. Yakovlev // Himiko-farmatsevticheskiy zhurnal. - 2013. - T 47, № 8. - S. 3-8.
14. Suhanova A.A. Sovremennyie aspektyi vedeniya zhenschin v klimaktericheskom periode / A.A. Suhanova, O.N. Tervazyuk // Zdorove zhenschin. - 2016. - № 5. - S. 130-136.
15. Tatarchuk TF Negormonalna terapIya klImakterichnih rozladIv / TF Tatarchuk, O.O. Efimenko, O.V. Zanko // Reproduktivna endokrinologIya. - 2016. - № 4. - S. 75-80.
16.  Haritonov S.V. Selektivnyie ingibitoryi obratnogo zahvata serotonina i suitsidalnyiy risk / S.V. Haritonov, L.G. Magurdumova // Suitsidologiya. - 2016. - T 7, № 1. - S. 46-54.
17. Bremner J.D. MRI-based measurement of hippocanipal volume in combat-related posttraumatic stress disorder / J.D. Bremner, P Randall, T.M. Scott [et al.] // American Journal of Psychiatry. - 2015. - Vol. 152. - P 973-981.
18. Camilleri M. A placebo-controlled trial of pricalopride for severe chronic constipation / M. Canilleri, R. Kerstens, A. Rylix [et al.] // N. Engl. J. Med. - 2008. - Vol. 358. - P 2344-2354.
19. Chanvel V. Estrogen dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: modelling the serotonin-ovarian hormone interaction in migraine aura / V. Chanvell, S. Multon, J. Schoenen // Cephalagia. - 2017. - Jan. 1: 333102417690891, — doi 10.1177/03331024176908911.
20. De Mayer J.H. 5-НТ4 receptor agonists: similar but not the same / J.H. De Mayer, R.A. Lefebre, J.A. Schurkes // Neurogastroenterol. - 2008. - Vol. 20. - P 99-112.
21. Drago A. SHT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPIS for future studies / A. Drago, D.D. Ronchi, A. Serrets // Int. J. Neuropsychopharmacology. - 2008. - Vol. 11, № 5. - Р 701-721.
22. Eddachibi S. The serotonin pathways in pulmonary hypertension / S. Eddachibi, S. Adnot // Arch. Mal. Coeur. Vaiss. - Vol. 99. - P 621-625.
23. Emanuelle E. An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress / E. Emanuelle, M. Bertona, P Minotti, D. Geroldi // Neuro Endocrinol Lett. - 2010. - Vol. 31, № 5. - Р 663-666.
24. Esposito M. A medical food formulation of Griffonia simplicifolia. Magnesia for childhood periodic syndrome therapy: an open label study on motor sickness / M. Esposito, F Presenzano M. Sorrentino [et al.] // J. Med. Food. - 2015. - Vol. 18, № 8. - Р 916-920.
25. Gustaffson B.I. Long-term serotonin administration induces heart valve disease in rats / B.I. Gustaffson, K. Tommeras, I. Nordrum [et al.] // Circulation. - 2005. - Vol. 111, № 12. - P. 1517-1522.
26. Hannon J. Molecular biology of 5-HT receptors / J. Hannon, D. Hoger // Behaw. Brain. Research. - 2008. - Vol. 195. - P 198-213.
27. Hariri A.R. Functional neuroimaging serotoninergic neurotransmission / A.R. Hariri, D.R. Weinberger // Genes. Brain and Dehavior.-    2003. - Vol. 2. - P 341-349.
28. Hayaeshi Y 5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord confusion in adult rats / Y Hayashi, S. Jacob-Vadakot, E.A. Dugan [et al.] // Exp. Neurol. - 2010. - Vol. 221, № 1. - Р 68-78.
29. Isakson G.A. Antidepressant and the risk of suicide in young person prescription trends and the toxicological analyses / G.A. Isaksson, J. Ahlea // Acts. Psychiat. - 2014. - Vol. 129, № 4. - P 296-302.
30. Jacobsen J. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale / J. Jacobsen, A.D. Krystal, M.G. Caron // Trends Pharmacol. Sci. - 2016. - Vol. 37, № 11. - Р 933-944.
31. Kim D.Y Serotonin: a mediator of the brain gut connection / D. Kim, M. Camilleri // Am. J. Gastroenterol. - 2000. - Vol. 95. - P 2698-2709.
32. Lanteri Minet M. An instrimentto assess patient perceptions of satisfaction with acute migraine treatment [EXDEP] study / M. Lanteri Minet, H. Massiou, S. Romafet [et al.] // Headache. - 2011. - Vol. 51. - P 590-601.
33. Ma Z. Characterization of serotonin toxicity syndrome (toxidrome) elicitated by 5-hydroxy-L-triptiphane in chlorgyline rats / Z. Ma, G. Zhangly, C. Jenney // J. Cur. Pharmacol. - 2008. - Vol. 588, № 2-3. - P 198-206.
34. Machida T Recent advances in 5-hydroxytryptamine (5-HT) receptor research: how many pathophysiological roles does 5-HT play via its multiple receptor subtypes? / T Machida, K. Iizuka, M. Hurafuji // Biol. Pharm. Bull. - 2013. - Vol. 36, № 9. - Р 1416-1419.
35. Muszynska B. Natural products of revelance in the prevention and supportive treatment of depression / B. Muszynska, M. Lolenski, J. Rolowski [et al.] // Psyciatr. Pol. - 2015. - Vol. 49, № 3. - Р 435-453.
36. Nakazawa Y The study of the effects of L-5HTP on the stages of sleeping man as evaluated by using sleping deprivation / Y Nakazawa, H. Hasazawa, T Kotorii [et al.] // Psychiatr. Neurolipn. - 1980. - Vol. 34, № 2. - P 83-87.
37. Negri L. Vittorio Esrameri (1909-1999) / L. Negri // Med. Secoli. - 2006. - P 97-113.
38. Nelson D.L. 5-НТ5 receptors / D.L. Nelson // Crrent drug targets CNS and neurological disordes. - 2004. - Vol. 3, № 1. - P 53-58.
39. Purushottam J. Comparative study of efficiency L-5-hydroxytryptophan and fluoxetine in patients presently with first depressive episode / J. Purushottam, M. Prema, D. Calie Ani Kumar // Asian J. Psychiatr. - 2013. - Vol. 6, № 1. - Р 29-34.
40. Quigley E.M. Clinical trial, the efficiency, impact on quality of life and safety and tolerability of prucalopride in severe chronic constipation a 12 week / E.M. Quigley, L. Wanderpeaasseche, R. Kertens // Aliment. Pharmacol. Ther. - 2009. - Vol. 29. - P 315-328.
41. Reinhold J.A. Pharmacological treatment for generalized anxiety disorders in adults / J.A. Reinhold, K. Rickels // Expert Opinion on Pharmacotherapy. - 2015. - Vol. 16, № 11. - Р 1669-1681.
42. Rondanelli M. Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration / M. Rondanelli, A. Opizzi, M. Faliva [et al.] // Eat Weight Disord. - 2012. - Vol. 17. - P 22-28.
43. Rupprecht R. Diagnosis and treatment of panic disorder / R. Rupprrecht, H.J. Moller // MMW Fprtschr. Med. - 2014. - Vol. 146, № 2. - Р 45-46.
44. Serretti A. Serotonin transporter gene variants and behavior: a comprehensive review / A. Seretti, A. Calatti, R. Mandelli [et al.] // Curr. Drugs. Targets. - 2006. - Vol. 7. - Р 1639-1669.
45. Sghendo L. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model / L. Sghendo, J. Mifsad // Journal of Parmacy and Pharmacology. - 2011. - Vol. 64. - P 317-325.
46. Tack J. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives / J. Tack, M.   Van Qutryge, G. Beyens [et al.] // Gut. - 2009. - Vol. 58. - P 357-365.
47. Tamann S. Major sleep disorders among women: (Women’s health series) / S. Tamann, S.A. Geraci // Southern Medical Journal. -    2013. - Vol. 106, № 8. - Р 470-478.
48. Terao T Serotonin syndrome in case of depression with various somatic symptoms: the difficulty in differential diagnosis / T Terdo, T NiKighi // Prog. Neuropsychopharmacol Biol. Psychiatry. - 2007. - Vol. 31, № 1. - Р 295-296.
49. Terron J.A. Pharmacological evidence that 50HT1B/1D receptors mediate hypotension in anesthetized rats / J.A. Terron, C. Sanchez-Maldonado, E. Martinez-Garcia // J. Pharmacol.Eur. J. Pharmacol. - 2007. - Vol. 576. - P 123-125.
50. Toffol E. Melatonin in perimenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life / Е. Toffol, N.   Kalleinen J. Haukka [et al.] // Menopause. - 2014. - Vol. 21. - P 493-500.
51. Tronci E. 5-hydroxytryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson’s disease model / E. Tronci, C. Disci, R. Stancampio [et al.] // Neurobiology of disease. - 2013. - Vol. 60. - P 108-114.
52. Turecki G.I. Suicide and serotonin’ study ofvariation at seven serotonin receptor genes in suicide ompleters / G.I. Turecki, A. Sequeira, Y Gingras [et al.] // Am. J. Med. Gebet/ B/ Neuropsychiatr. Genet. - 2003. - Vol. 11813, № 1. - Р 36-40.
53. Turner E.H. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptofan / E.H. Turner, J.M. Loftis, A.D. Blackwell // Pharmacol. Ther. - 2006. - Vol. 109, № 3. - P 325-328.
54. Twarog B.M. Serotonin content of some mammalian tissues and method of its determination / B.M. Twarog, I.H. Page // Am. J. Physiol. - 1953. - Vol. 75, № 1. - P 157-161.
55. Yaqing Li Synthesis, transport and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats / Li Yaqing, Li Lisa, S.J. Marilice [et al.] // J. of Neurophysiology. - 2014. - Vol. 111, № 11. - Р 145-163.

«Вестник проблем биологии и медицины» Выпуск 3 Том 1 (137), 2017 год, 49-56 страницы, код УДК 615.275:612.327